WO1996024381A3 - Kontrastmittelhaltige liposomen für die darstellung des intravasalraumes - Google Patents
Kontrastmittelhaltige liposomen für die darstellung des intravasalraumes Download PDFInfo
- Publication number
- WO1996024381A3 WO1996024381A3 PCT/EP1996/000539 EP9600539W WO9624381A3 WO 1996024381 A3 WO1996024381 A3 WO 1996024381A3 EP 9600539 W EP9600539 W EP 9600539W WO 9624381 A3 WO9624381 A3 WO 9624381A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood pool
- contrast media
- liposomes containing
- containing contrast
- pool imaging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
- A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96904033A EP0806969A2 (de) | 1995-02-09 | 1996-02-09 | Kontrastmittelhaltige liposomen für die darstellung des intravasalraumes |
AU47890/96A AU4789096A (en) | 1995-02-09 | 1996-02-09 | Liposomes containing contrast media for blood pool imaging |
JP8523999A JPH10513466A (ja) | 1995-02-09 | 1996-02-09 | 脈管内空間を視覚化するための造影剤を含むリポソーム |
NO973666A NO973666L (no) | 1995-02-09 | 1997-08-08 | Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19505813 | 1995-02-09 | ||
DE19505813.5 | 1995-02-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996024381A2 WO1996024381A2 (de) | 1996-08-15 |
WO1996024381A3 true WO1996024381A3 (de) | 1996-10-03 |
Family
ID=7754530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/000539 WO1996024381A2 (de) | 1995-02-09 | 1996-02-09 | Kontrastmittelhaltige liposomen für die darstellung des intravasalraumes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0806969A2 (de) |
JP (1) | JPH10513466A (de) |
AU (1) | AU4789096A (de) |
CA (1) | CA2212162A1 (de) |
DE (1) | DE19606326A1 (de) |
NO (1) | NO973666L (de) |
WO (1) | WO1996024381A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19529922A1 (de) * | 1995-08-01 | 1997-02-06 | Schering Ag | Verwendung von liposomalen Zubereitungen in der indirekten MRT-Lymphographie |
GB9624918D0 (en) * | 1996-11-29 | 1997-01-15 | Nycomed Imaging As | Particulate components |
AU5260301A (en) * | 2000-04-28 | 2001-11-12 | Fuji Photo Film Co Ltd | Liposomes containing hydrophobic iodo compound |
JPWO2006009022A1 (ja) * | 2004-07-21 | 2008-05-01 | コニカミノルタエムジー株式会社 | リポソーム含有x線造影剤およびその製造方法 |
JP5176320B2 (ja) * | 2004-08-11 | 2013-04-03 | コニカミノルタエムジー株式会社 | リポソーム含有製剤の製造方法 |
EP2606912A1 (de) * | 2011-12-23 | 2013-06-26 | Central Medical Service Co., Ltd. | Kontrastmittelzusammensetzung mit Kontrastverstärkungseffekt aufgrund des Umfassens eines hoch konzentrierten Mittels |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0179444A2 (de) * | 1984-10-22 | 1986-04-30 | Vestar, Inc. | Verwendung eines Mittels mit chemotherapeutische Substanz einkapselnden Mizellteilchen für intravenöses Tumortargeting |
WO1988001505A1 (en) * | 1986-08-29 | 1988-03-10 | The Government Of The United States Of America, As | Scaled-up production of liposome-encapsulated hemoglobin |
WO1990004943A1 (en) * | 1988-11-09 | 1990-05-17 | Unger Evan C | Liposomal radiologic contrast agents |
EP0405704A2 (de) * | 1989-06-30 | 1991-01-02 | Schering Aktiengesellschaft | Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung |
WO1991005599A1 (de) * | 1989-10-13 | 1991-05-02 | Schering Aktiengesellschaft Berlin Und Bergkamen | Verfahren zur herstellung von wässrigen dispersionen |
WO1994008565A1 (en) * | 1992-10-14 | 1994-04-28 | The Liposome Company, Inc. | Interdigitation-fusion liposomes and gels |
WO1994008626A1 (de) * | 1992-10-16 | 1994-04-28 | Andreas Sachse | Verfahren und vorrichtung zur herstellung flüssiger, disperser systeme |
WO1995015153A1 (de) * | 1993-12-02 | 1995-06-08 | Schering Aktiengesellschaft | Verfahren zur erhöhung der stabilität von hydrophile wirkstoffe enthaltenden liposomensuspensionen |
DE4426438A1 (de) * | 1994-07-26 | 1996-02-01 | Schering Ag | Verwendung von Chelaten als Röntgenkontrastmittel |
-
1996
- 1996-02-09 WO PCT/EP1996/000539 patent/WO1996024381A2/de not_active Application Discontinuation
- 1996-02-09 DE DE19606326A patent/DE19606326A1/de not_active Withdrawn
- 1996-02-09 JP JP8523999A patent/JPH10513466A/ja active Pending
- 1996-02-09 CA CA 2212162 patent/CA2212162A1/en not_active Abandoned
- 1996-02-09 AU AU47890/96A patent/AU4789096A/en not_active Abandoned
- 1996-02-09 EP EP96904033A patent/EP0806969A2/de not_active Withdrawn
-
1997
- 1997-08-08 NO NO973666A patent/NO973666L/no unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0179444A2 (de) * | 1984-10-22 | 1986-04-30 | Vestar, Inc. | Verwendung eines Mittels mit chemotherapeutische Substanz einkapselnden Mizellteilchen für intravenöses Tumortargeting |
WO1988001505A1 (en) * | 1986-08-29 | 1988-03-10 | The Government Of The United States Of America, As | Scaled-up production of liposome-encapsulated hemoglobin |
WO1990004943A1 (en) * | 1988-11-09 | 1990-05-17 | Unger Evan C | Liposomal radiologic contrast agents |
EP0405704A2 (de) * | 1989-06-30 | 1991-01-02 | Schering Aktiengesellschaft | Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung |
WO1991005599A1 (de) * | 1989-10-13 | 1991-05-02 | Schering Aktiengesellschaft Berlin Und Bergkamen | Verfahren zur herstellung von wässrigen dispersionen |
WO1994008565A1 (en) * | 1992-10-14 | 1994-04-28 | The Liposome Company, Inc. | Interdigitation-fusion liposomes and gels |
WO1994008626A1 (de) * | 1992-10-16 | 1994-04-28 | Andreas Sachse | Verfahren und vorrichtung zur herstellung flüssiger, disperser systeme |
WO1995015153A1 (de) * | 1993-12-02 | 1995-06-08 | Schering Aktiengesellschaft | Verfahren zur erhöhung der stabilität von hydrophile wirkstoffe enthaltenden liposomensuspensionen |
DE4426438A1 (de) * | 1994-07-26 | 1996-02-01 | Schering Ag | Verwendung von Chelaten als Röntgenkontrastmittel |
Non-Patent Citations (1)
Title |
---|
CAPELLIER M ET AL: "RADIOPAQUE LIPOSOMES FOR COMPUTED TOMOGRAPHY OPACIFICATION", CARDIOLOGY AND IMAGING, NEW ORLEANS, NOV. 4 - 7, 1988, vol. 10 PART 1/04, 4 November 1988 (1988-11-04), HARRIS G;WALKER C, pages 491 - 492, XP000093331 * |
Also Published As
Publication number | Publication date |
---|---|
CA2212162A1 (en) | 1996-08-15 |
WO1996024381A2 (de) | 1996-08-15 |
NO973666D0 (no) | 1997-08-08 |
NO973666L (no) | 1997-10-08 |
AU4789096A (en) | 1996-08-27 |
JPH10513466A (ja) | 1998-12-22 |
DE19606326A1 (de) | 1996-08-22 |
EP0806969A2 (de) | 1997-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1158959B1 (de) | Zusammensetzungen und verfahren zur verbesserten verabreichung hydrophober therapeutischer wirkstoffe | |
AU2076895A (en) | Liposomes | |
CA2213861A1 (en) | Method for loading lipid vesicles | |
Forssen et al. | Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors | |
US4920016A (en) | Liposomes with enhanced circulation time | |
US5009819A (en) | Taste moderating composition | |
CA2196780A1 (en) | A liposomal delivery system comprising cationic lipopolyamines and neutral lipids for delivery of biologically active agents | |
RU97102349A (ru) | Композиция для получения лекарственного средства (варианты) и способ ее получения | |
AU608264B2 (en) | Delivery vehicles with amphiphile-associated active ingredient | |
CA2119253A1 (en) | Medication Vehicles Made of Solid Lipid Particles (Solid Lipid Nanospheres-SLN) | |
CA2033725A1 (en) | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid | |
WO2001039744A3 (en) | Radiation sensitive liposomes | |
NZ503568A (en) | Biphasic lipid vesicle composition for transdermal administration of an immunogen | |
CA2117769A1 (en) | Liposome composition | |
WO1996024381A3 (de) | Kontrastmittelhaltige liposomen für die darstellung des intravasalraumes | |
Buiting et al. | Biodistribution of clodronate and liposomes used in the liposome mediated macrophage ‘suicide’approach | |
EP0510086B1 (de) | Interdigitation-fusionsliposomen und gele | |
WO2001082892A3 (de) | Wirkstoffhaltige liposome | |
Utkhede et al. | Effect of lipid dose on the redistribution and blood pool clearance kinetics of peg-modified technetium-labeled lipid vesicles | |
WO1998001124A3 (en) | Pharmaceutical preparation containing nimesulide for topical use | |
Gregoriadis et al. | Fate of liposomes in vivo: control leading to targeting | |
Hodis et al. | In vivo hypertensive arterial wall uptake of radiolabeled liposomes. | |
CA2271735A1 (en) | Magnetic resonance blood pool agents | |
AR002735A1 (es) | Formulaciones liquidas de sustancias insecticidas activas. | |
EP0429442B1 (de) | Zahnbehandlung durch freisetzung von vesikeln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA CN HU JP KR NO NZ SG US VN AZ BY KG KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA CN HU JP KR NO NZ SG US VN AZ BY KG KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996904033 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2212162 Country of ref document: CA Ref country code: CA Ref document number: 2212162 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 523999 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996904033 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1998 875941 Date of ref document: 19980323 Kind code of ref document: A Format of ref document f/p: F |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996904033 Country of ref document: EP |